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Abstract
Background—The Short Physical Performance Battery (SPPB) is a well-established measure of 
lower body physical functioning in older persons but has not been adequately examined in African 
Americans or younger persons. Moreover, factors associated with changes in SPPB over time have 
not been reported.
Methods—A representative sample of 998 African Americans (49–65 years old at baseline) 
living in St. Louis, Missouri were followed for 36 months to examine the predictive validity of 
SPPB in this population and identify factors associated with changes in SPPB. SPPB was 
calibrated to this population, ranged from 0 (worst) to 12 (best), and required imputation for about 
50% of scores. Adverse outcomes of baseline SPPB included death, nursing home placement, 
hospitalization, physician visits, incident basic and instrumental activity of daily living disabilities, 
and functional limitations. Changes in SPPB over 36 months were modeled.
Results—Adjusted for appropriate covariates, weighted appropriately, and using propensity 
scores to address potential selection bias, baseline SPPB scores were associated with all adverse 
outcomes except physician visits, and were marginally associated with hospitalization. Declines in 
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SPPB scores were associated with low falls efficacy (b = −1.311), perceived income adequacy 
(−0.121), older age (−0.073 per year), poor vision (−0.754), diabetes mellitus (−0.565), refusal to 
report household income (1.48), ever had Medicaid insurance (−0.610), obesity (−0.437), 
hospitalization in the year prior (−0.521), and kidney disease (−.956).
Conclusions—The effect of baseline SPPB on adverse outcomes in this late middle-age African 
American population confirms reports involving older, primarily white participants. Alleviating 
deterioration in lower body physical functioning guided by the associated covariates may avoid or 
delay multiple age-associated adverse outcomes.
Keywords
Aging; Lower body physical functioning; Disability; African Americans; Mortality; Nursing home 
placement
The Short Physical Performance Battery (SPPB) developed from the Established 
Populations for Epidemiological Study of the Elderly (EPESE) is based on standing balance, 
chair stands, and gait speed. In older adults, SPPB is a strong and consistent predictor of 
progressive disability, hospitalization, nursing home admission, and death (1–6). Easy to 
administer in both epidemiological (5,7) and clinical settings (8,9), SPPB has excellent test–
retest reliability and sensitivity to change (7). Moreover, it has been suggested that SPPB 
may be used to identify seniors in a “preclinical” stage of disability who may be ideal 
candidates for interventions aimed at delaying or preventing age-associated disability (2).
This knowledge notwithstanding, the predictive validity of SPPB has not been investigated 
in persons younger than 65 years, nor has it not been evaluated specifically for the African 
American population. African Americans constitute an important, disadvantaged U.S. 
minority population with increased risk for disability (10); lower body dysfunction 
represents one of the most powerful predictors of falls, hip fractures, incident disability, 
nursing home placement, and mortality [e.g., (2,11–14)]; and African Americans compared 
to whites generally have different experiences related to lower body physical performance 
such as prevalence of deficits, types of falls, and performance-related life space mobility 
[e.g., (15–17)]. For these reasons, examination of the predictive validity of SPPB in this 
population is crucial. Moreover, factors associated with changes in SPPB over time have not 
been examined using multivariable methods in well-designed population-based studies. 
After being identified, factors associated with subsequent change in SPPB could inform 
interventions to prevent decline in lower body function and thus avoid or delay multiple age-
associated adverse outcomes. Accordingly, we used data from the African American Health 
(AAH) project to address the predictive validity of SPPB in late middle-aged African 
Americans and to examine correlates in changes in SPPB over time. We hypothesized that 
SPPB would be associated with death, nursing home placement, hospitalization, physician 
visits, incident basic and instrumental activity of daily living (ADL) disabilities, and 
functional limitations. We anticipated that correlates of change in SPPB over time would 
include older age, female gender, disease status (e.g., diabetes, stroke), poor vision, poor 
self-rated health, underweight and obesity, cigarette smoking, physical inactivity, clinically 
relevant levels of depressive symptoms, adverse neighborhood conditions, and recent 
hospitalization.
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METHODS
Study Sample
The AAH project has been previously described (18,19). In brief, AAH is a population-
based random sample study of 998 African Americans born in 1936 through 1950 from two 
diverse socioeconomic areas of St. Louis, Missouri (recruitment rate 76%). One area 
involved inner-city neighborhoods, and the other involved suburbs just northwest of St. 
Louis city with generally better socioeconomic circumstances. Additional inclusion criteria 
included self-reported black or African American race, ability and willingness to sign 
informed consent, and a Mini-Mental State Examination (MMSE) (20) score of 16 or greater 
(21). To recruit equal numbers of participants from both areas, unequal sampling 
proportions were used. When the original sample weight is used, the AAH cohort represents 
the noninstitutionalized African American population in the two areas as of the 2000 census. 
Baseline (wave 1) evaluations occurred in the participant’s home between September 2000 
and July 2001. Interviewers completed 26 hours of training on study-specific interviewing 
and performance testing. All procedures were approved by the Institutional Review Boards 
at the involved institutions, and all participants gave written informed consent.
Follow-Up Sample
In-home evaluations (wave 4) were again conducted 36 months after baseline. Eight hundred 
fifty-three participants were re-evaluated, with five of the evaluations relying on a proxy 
source previously identified by the participant. Because 51 participants had died between 
baseline and 36-month follow-up, the response rate for survivors was 90.1%. Attrition 
analysis (data available on request) indicated that dropout status was associated only with 
better vision and diagnoses of cancer and heart disease. Given the large number of factors 
included in the attrition analyses, it is likely that some of these three findings are due to 
chance. Furthermore, because the three associations were modest in size, the potential for 
meaningful attrition bias is minimal.
SPPB Measure
We constructed SPPB component and summary scores for the wave 1 and wave 4 
evaluations based on the method described by Guralnik and colleagues (1,5) and Ostir and 
colleagues (7). The SPPB summary score is composed of three lower body physical 
performance measures: a hierarchical test of standing balance, five consecutive chair rises, 
and usual gait speed. Standardized assessment protocols were used, with interviewers 
demonstrating each task to participants before the evaluation. For each component score, 
participants who were deemed unable, unsafe, or in too much pain to attempt the task or 
were unable to complete the lowest performance level were given a task score of zero.
Standing balance was evaluated and scored using a hierarchical set of tasks based on side-
by-side, semi-tandem, and tandem stances, as described by Guralnik and colleagues (1,5). 
For the chair stands evaluation, participants were asked to sit in a sturdy straight-back chair 
with the seat distance from the ground appropriate for the participants’ height, to fold their 
arms across their chests, and to complete five chair rises as quickly as possible. Scores of 1 
to 4 were based on quartiles of performance of AAH project participants who were able to 
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complete the task, as follows: a score of 1 for >13.80 seconds; a score of 2 for 11.38–13.79 
seconds; a score of 3 for 9.18–11.37 seconds; and a score of 4 for ≤9.17 seconds. For the 
habitual gait speed, a standardized 3- or 4-m course was demarcated in participants’ homes, 
with participants instructed to walk at their usual pace, as if walking to the store. The 
average walking speed (m/s) for two trials was used to determine scores of 1–4 based on 
quartiles of performance for AAH participants who completed both walks. As gait speeds 
for 4 m were systematically faster than those for 3 m due to the effect of acceleration from 
the initial standing position, separate cut points were determined for the two distances, as 
follows: for 3 m (n = 244), a score of 1 for ≤0.60 m/s, a score of 2 for 0.61–0.72 m/s; a score 
of 3 for 0.73–0.86 m/s; and a score of 4 for ≥0.87 m/s. For 4 m (n = 241): a score of 1 for 
≤0.70 m/s, a score of 2 for 0.71–0.81 m/s; a score of 3 for 0.82–0.97 m/s; and a score of 4 
for ≥0.98 m/s. Due to safety concerns and challenges from cluttered, relatively small living 
spaces, gait speed participation was low during wave 1 but improved during wave 4 due to 
improved interviewer training and problem-solving during in-home interviewing.
A summary score was created by adding the component scores for standing balance, chair 
stands, and usual gait speed (range from 0 [worst] to 12 [best]). Using the approach 
employed by Ostir and colleagues (7), when one of the three measures was missing, the total 
score was calculated as the average of the other two scores times 3. When two of the three 
measures were missing, no total score was calculated. Adequate data were available to score 
the following at wave 1 and wave 4, respectively: 91.6% and 93.0% for standing balance, 
89.2% and 87.5% for chair stands, 44.9% and 79.8% for gait speed, and 91.0% and 91.1% 
for the summary score. The physical performance tests were repeated about 2 weeks later 
(mean 18 days, standard deviation [SD] 6.9) on 28 participants, and the test–retest reliability 
using the intraclass correlation coefficient was 0.727.
Predictive Validity Measures
To examine the predictive validity of SPPB, we evaluated the relationship between the 
SPPB summary score at baseline and the following outcomes obtained during the wave 4 
evaluation. Vital status was measured as alive versus dead and determined through the 
tracking efforts of the contracting survey organization (Survey Research Center at the 
University of Michigan). Nursing home placement for a long-term stay (i.e., short-term 
rehabilitation stays were not counted) was measured in a similar fashion, supplemented with 
specific questions during the wave 4 interview. Tracking was successful for all 998 of the 
original respondents. Hospitalization was based on respondent or (in five cases) proxy 
reports at the wave 4 interview of one or more hospitalizations in the year prior to the 36-
month follow-up. Physician visits were based on respondent (or proxy) report of the number 
of non–emergency room physician visits in the year prior to the 36-month followup. Seven 
basic ADLs were taken from the Second Longitudinal Study on Aging (LSOA-II) (22) and 
included having any difficulty with bathing, dressing, eating, getting in and out of bed or 
chairs, walking across a room, getting outside, and using the toilet (0 = no difficulties to 7 = 
difficulties on all activities). Eight instrumental ADL items from LSOA-II and Lawton and 
Brody (23) included reporting any difficulty with preparing meals, shopping for groceries, 
managing money, making phone calls, doing light housework, doing heavy housework, 
getting to places outside of walking distance, and managing medications (0 = no difficulties 
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to 8 = difficulties on all activities). Lower body functional limitations were measured as the 
sum of reported difficulty for five activities (walking one quarter mile, going up and down a 
flight of 10 steps, stooping–crouching–kneeling, lifting 10 pounds, and pushing large 
objects).
Measurement of Potential Correlates of Change in SPPB Measures
The following baseline covariates were used in multi-variable models to identify factors 
associated with change in the SPPB summary measures from wave 1 to wave 4. 
Demographic measures included age (continuous variable), gender, and marital status. 
Socioeconomic measures involved years of formal education, annual household income (<
$20,000 vs ≥$20,000; 4.3% refused to report household income), perceived income 
adequacy (comfortable or not enough vs reference category of just enough to make ends 
meet), having Medicare now (yes vs no), ever having Medicaid, and stratum (inner city vs 
suburbs). Health conditions included self-rated health (24) and a five-level self-rated 
assessment of hearing ranging from excellent to poor (each dichotomized as fair or poor vs 
all others). A self-reported visual acuity scale (3 = excellent to 15 = poor) was coded as the 
lowest quintile versus all others. Severe underweight was defined as a body mass index 
(BMI) <20, obesity as a BMI of ≥30, with the reference category being 20 ≥BMI < 30 (BMI 
could not be determined in 1.6%). The presence of chronic disease was based on self-report 
of physician diagnosis for 11 diseases or conditions (hypertension, diabetes mellitus, stroke, 
heart attack, cancer other than a minor skin cancer, chronic obstructive pulmonary disease 
[COPD], heart failure, angina, asthma, kidney disease, and arthritis). Current and previous 
cigarette smokers were contrasted with the reference group of never smokers. Physical 
activity was measured with the frequency of walking one-quarter mile (1 to 6 times per 
week or 7 or more time per week vs < 1 time per week; 2.7% missing) and with the 
seasonally adjusted summary index from the Yale Physical Activity Scale (25). Chronic 
disease incidence over 36-month follow-up for the 11 conditions listed above was 
categorized as 1 incident condition or ≥2 incident conditions vs no incident conditions. 
Psychosocial measures involved the following: Depressive symptoms were measured using 
the 11-item Center for Epidemiological Studies Depression (CES-D) short form and coded 
as 1 if ≥9 points and 0 if <9 points (26,27). Cognitive function was measured using the 
MMSE and Animal Naming tests (28,29), with the lowest quintile contrasted with all others 
(5.8% missing Animal Naming). Fear of falling was measured using the Falls Efficacy Scale 
(30), contrasting the lowest quintile versus all others. The five-item social support scale was 
derived from the Medical Outcomes Study (5 = worst to 25 = best) (31) and coded as lowest 
quintile or missing (0.4%) versus all others. The religiosity scale (5 = highest to 33 = lowest) 
was based on five items from the Fetzer Institute/National Institute on Aging Working 
Group measures (32) and coded as the lowest quintile or missing (0.8%) versus all others. 
Race consciousness was measured by asking participants how often they thought about their 
race (33), with those responding never or only once a year (42.2%) contrasted with all 
others. Neighborhood desirability was assessed by a self-reported four-item scale, which 
was recoded to contrast living in the least desirable quintile versus all others. Home 
assessment was a five-item scale of the interviewer’s ratings of the interior and exterior of 
the home (5 = excellent to 20 = poor), and the lowest quintile was contrasted to all others 
(3.0% missing). Neighborhood assessment was a five-item scale of the interviewer’s ratings 
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of block face conditions (5 = best to 20 = worst), and the lowest quintile was contrasted with 
all others. Health services use was measured by whether the respondent had been 
hospitalized in the year prior to the baseline interview, based on self-report. More details of 
the covariate measurements are available in previous publications (27,29,34).
Statistical Analysis
Because a large number of participants were missing gait speed at wave 1, the propensity 
score method for addressing potential selection bias was used for all analyses except one of 
the sensitivity analyses. In brief, a multivariable logistic regression of whether gait speed 
was obtained on the participant at wave 1 was run using the variables described in the 
Methods section as potential predictor variables, and the predicted probability of inclusion in 
the gait speed group was determined for each participant in the study sample. The predicted 
probabilities were divided into quintiles, and the average participation rate within each 
quintile was calculated. Then the inverse (1 − participation rate) was used to weight the data 
so that participants with gait speeds who were most like those participants without gait 
speeds were given proportionally greater influence on the results (35,36). (Factors associated 
with lack of participation in wave 1 gait speed in the propensity-score model are available 
on request.)
Baseline characteristics were compared across tertiles of the SPPB using analysis of 
variance for continuous variables and the chi-square test for categorical variables. The 
relationship of the baseline SPPB summary scores with subsequent vital status, nursing 
home placement, and hospitalization was examined using logistic regression. The vital status 
model was adjusted for baseline age, gender, education, and self-rated health, and the model 
for the other two outcomes was adjusted for these variables plus incident conditions. The 
association of the baseline SPPB summary scores with the subsequent number of physician 
visits, basic and instrumental ADL disabilities, and lower body functional limitations was 
examined using residual change score linear regression, adjusting for the baseline level of 
the outcome as well as age, gender, education, self-rated health, and incident conditions. 
Factors associated with changes in the SPPB summary score over time were also identified 
using residual change score regression. In these analyses, the covariates were sequentially 
entered in the following block sequence: baseline SPPB summary score, demographic 
factors, socioeconomic measures, health conditions, psychosocial measures, and health 
services use (37). Dummy variables were used to represent missing data (when >1%) for 
each covariate. Variables independently associated with changes in the SPPB summary 
measure within their block were retained for the next step, and all variables retained in this 
process were included in final forced-entry regression analyses (unweighted n of participants 
included = 687).
In sensitivity analyses, robustness of the results was evaluated first using two alternative 
methods for scoring the SPPB summary measure. In one method, participants who had 
missing data for a single component task (e.g., chair stands) were given a 0 for that task to 
maximize the number of participants in the analysis. In the other method, summary SPPB 
scores were computed only when data were available for all three component tasks, which 
minimized the number of participants available (to 474 for the outcome assessments and to 
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346 for evaluating changes in SPPB over time). These analyses used propensity-score 
weighting. Then a third sensitivity analysis was conducted, which used the original scoring 
method but used the original sample weight rather the propensity-score weight.
RESULTS
Descriptive Data
Baseline characteristics are noted in Table 1, along with their association with tertiles of the 
wave 1 SPPB summary score. By the 36-month follow-up, of the 853 assessed participants, 
6.0% had died, 2.5% had been admitted to a nursing home for what was considered a 
permanent stay, 20.2% had experienced one or more hospitalizations in the prior year, and 
the mean number of physician visits in the prior year, basic and instrumental ADL 
disabilities, and lower body functional limitations were 6.32 (SD 10.32), 0.88 (SD 1.74), 
1.16 (SD 1.83), and 1.50 (SD 1.53), respectively. Average SPPB summary scores were 7.65 
(SD 3.54) at baseline and 8.06 (SD 2.95) at 36-month follow-up. At baseline, 49% scored 
<9, and at 36-month follow-up 47% scored <9. Thirty-six-month SPPB change scores 
averaged 0.16 (SD 2.71), inter-quartile range −1.5 to 2.0, with negative scores indicating a 
decline in SPPB. A decline of one point or more SPPB points was experienced by 39% of 
participants, 38% improved ≥1 points, and 23% stayed the same.
Predictive Validity
After appropriate adjustments, each 1-point increase in the baseline SPPB score was 
independently associated with a 12% relative decrease in the risk of death, a 21% decrease 
in the risk of nursing home placement, and a 5% decrease in the risk of hospitalization, 
although this last result only reached borderline statistical significance (Table 2). The 
baseline SPPB summary score was also an independent predictor of changes in basic and 
instrumental ADL disabilities and lower body functional limitations over the 36-month 
period (Table 3). On average, for each additional 1 point on the baseline SPPB summary 
score (6), the net increase in the number of disabilities and limitations was reduced by about 
0.1 on each of the basic ADL, instrumental ADL, and lower body functional limitations 
scales. Although the crude association of the baseline SPPB score was significantly 
associated with change in the number of physician visits, this relationship was not 
significant in the multivariable model.
Correlates of Change in the SPPB Summary Score
The results of the multivariable change score regression analysis of the SPPB summary 
score are shown in Table 4. As expected, the largest association involved the baseline SPPB 
summary score. Changes in the SPPB summary score over time were associated, from 
highest to lowest relative magnitude (using the standardized regression coefficient), with 
low falls efficacy, comfortable perceived income, age, poor vision, diabetes mellitus, refusal 
to report income, ever having Medicaid, BMI ≥30, hospitalization in the year prior to 
baseline, and kidney disease. With the exception of refusal to report income, the presence of 
each risk factor was associated with a decline in the SPPB summary score over the 36-
month period.
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Sensitivity Analysis
As indicated above, all of the models were replicated using three different approaches to 
scoring the SPPB and analyzing the data. In these analyses, the results of both the predictive 
validity and correlates of change in the SPPB summary score over time were materially 
similar to those using the original method. Most of the differences involved fewer 
statistically significant results when the more restrictive inclusion criterion resulted in fewer 
participants in the analytic sample, although the point estimates obtained were similar (data 
available from authors).
DISCUSSION
Previous research has shown that lower body function is crucial for avoiding or delaying 
health problems that often accompany older age, such as falls, progressive disability, 
institutionalization, and mortality. Our study extends previous research regarding the 
association of SPPB with adverse outcomes in samples of mixed or primarily white race (1–
6) to mortality, nursing home placement, and progressive basic ADL, instrumental ADL, 
and lower body functional difficulties in a probability-based sample of urban-dwelling 
African Americans. Moreover, our findings demonstrate that these relationships are 
important for persons in late middle age as well as for older adults, when SPPB is calibrated 
for the younger group.
Of probably greater importance is the identification of factors independently associated with 
changes in SPPB summary scores over the 36-month period in this population. There are 
two reasons why these results are so important. First, factors associated with declines in 
SPPB summary scores over time can be used as an early warning system to identify persons 
at greater risk for subsequent declines in essential lower body functioning. The substantial 
independent association of low falls efficacy with declines in SPPB summary scores is of 
particular interest and appears similar to the well-known ability of a self-reported general 
health question to independently predict mortality (e.g., 38). Although it is unclear from 
these data whether low falls efficacy taps information that predicts a natural decline in lower 
body physical functioning or whether it acts like a self-fulfilling prophecy, low falls efficacy 
remains a strong predictor of decline in lower body function.
Some of our findings appear to vary from those of other investigations examining the 
relationship between physical functioning and the covariates that we studied. For example, 
in cross-sectional studies, Malmstrom and colleagues (29) identified associations between 
cognitive and physical functioning, and Brach and colleagues (39) found that participants 
who reported being physically active had better physical performance than did inactive 
participants. In a longitudinal study, Mendes de Leon and colleagues (40) showed that social 
relationships were important in the disability process, with similar findings in blacks and 
whites. Differences in design probably explain these discrepancies.
Second, these findings suggest treatment approaches for patients most in need of assistance 
in midlife to prevent subsequent declines in lower body functioning. For example, 
interventions are available to increase falls efficacy (41,42), to improve the physical and 
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social impacts of low vision (43), and to improve outcomes in persons recently discharged 
from the hospital (44,45).
The primary limitation of this study is the restricted number of participants with gait speed 
assessments at baseline. However, we used the best available method for addressing the 
potential selection bias related to gait speed acquisition to obtain our results. Furthermore, 
two different methods for dealing with missing gait speeds and one method using a different 
approach to weighting the data produced equivalent results in both the predictive validity 
analyses and the analyses of changes in SPPB summary scores over the 36-month period. 
Together, these increase our confidence that the results shown in Tables 2–4 are robust. 
Other, less important limitations of this study relate to the single race-ethnic group, the 
single metropolitan area, and the limited age range. Although these are distinct advantages 
of the internal validity of our study, they do constrain its generalizability. This is critical for 
the identification of factors associated with declines in SPPB over time, and further studies 
to replicate these analyses are essential.
Summary
This study has confirmed the predictive validity of SPPB for adverse health outcomes in a 
population-based cohort of late middle-aged, urban-dwelling African Americans, when 
SPPB is calibrated for that population. Moreover, the factors associated with changes in 
SPPB over 36 months suggest avenues that may be useful to both researchers and clinicians 
for preventing declines in important lower body functioning in late middle age that may 
avoid or delay multiple age-associated adverse outcomes. Additional studies replicating 
these analyses in other middle-aged populations are needed.
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Table 2
Baseline Short Physical Performance Battery (SPPB) Summary Scores by Vital Status, Nursing Home 
Placement, and Hospitalization Over the 36-Month Follow-Up, and Adjusted Odds Ratios (OR) Obtained 
Using Multivariable Logistic Regression*
Variables Mean SPPB (SD)
Logistic Regression
Adjusted OR 95% CI p Value
Vital status† 0.88 0.81–0.95 .002
 Dead (1) 5.59 (3.87)
 Alive (0) 7.78 (3.49)
Nursing home placement‡ 0.79 0.65–0.96 .02
 Yes (1) 3.91 (5.04)
 No (0) 7.89 (3.42)
Hospitalization‡ 0.95 0.90–1.00 .08
 ≥1 (1) 7.13 (3.86)
 None (0) 8.01 (3.35)
Notes:
*Separate logistic regression computed for each variable, using propensity-score weighted data.
†Adjusted for baseline age, gender, years of education, and self-rated health (fair/poor vs excellent/very good/good).
‡Adjusted for baseline age, gender, years of education, self-rated health (fair/poor vs excellent/very good/good), and incident conditions (1 or 2 or 
more vs none).
SD = standard deviation; CI = confidence interval.
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Table 3
Residual Change Score Linear Regression Analysis Results for Baseline Short Physical Performance Battery 
(SPPB) Summary Scores on Physician Visits, ADL Disabilities, IADL Disabilities, and Functional 
Limitations at the 36-Month Follow-Up
Variables
Residual Change Score Multiple Linear Regression
B Standardized Beta p Value
Physician visits* −0.124 −0.040 .31
ADL disabilities† −0.123 −0.259 <.001
IADL disabilities‡ −0.121 −0.245 <.001
Lower body functional limitations§ −0.084 −0.192 <.001
Notes: Separate ordinary least squares regression computed for each variable, using weighted data.
*Adjusted for baseline physician visits, age, gender, education, self-rated health (fair/poor vs excellent/very good/good), and incident conditions (1 
or 2 or more vs none).
†Adjusted for baseline ADL disabilities, age, gender, education, self-rated health (fair/poor vs excellent/very good/good), and incident conditions 
(1 or 2 or more vs none).
‡Adjusted for baseline IADL disabilities, age, gender, education, self-rated health (fair/poor vs excellent/very good/good), and incident conditions 
(1 or 2 or more vs none).
§Adjusted for baseline lower body functional limitations, age, gender, education, self-rated health (fair/poor vs excellent/very good/good), and 
incident conditions (1 or 2 or more vs none).
ADL = activities of daily living; IADL = instrumental ADL.
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Table 4
Baseline Factors Associated With 36-Month Changes in the Short Physical Performance Battery (SPPB) 
Summary Scores Obtained From Residual Change Score Multiple Linear Regression Analyses
Factors B Standardized Beta p Value
Baseline SPPB summary score 0.347 0.404 <.001
Age −0.073 (per y) −0.113 <.001
Education .036 .037   .22
Household income
 <$20,000 vs ≥$20,000 −.317 −.052 −.13
 Refusal to report vs ≥$20,000 1.48 .084   .002
Perceived income adequacy
 Comfortable income vs Just enough to get by −0.680 −0.121 <.001
 Not enough make to ends meet vs Just enough to get by −0.266 −0.036   .25
Medicare coverage (current vs previous/no) −0.282 −0.036   .24
Medicaid coverage (current/previous vs never) −0.610 −0.082   .007
Poor vision (worst quintile) −0.754 −0.102 <.001
Body mass index
 <20.0 vs 20.0 – <30.0 0.144 0.009   .75
 ≥30.0 vs 20.0 – <30.0 −0.437 −0.077   .007
 Unknown vs 20.0 – <30.0 −0.062 0.003   .92
Diabetes mellitus −0.565 −0.086   .003
Chronic lung condition −0.628 −0.051   .06
Kidney disease −0.956 −0.058   .04
Low efficacy quintile) falls (worst −1.311 −0.171 <.001
Hospitalized in past tear −0.521 −0.066   .03
Model N (unweighted) 687
Model R2 .527
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